Press Release

Middle East & Africa Pharmaceutical Grade Sodium Chloride Market Likely to Rise Due to Surging Drug Development Activities

The Middle East & Africa Pharmaceutical Grade Sodium Chloride Market is projected to grow at a CAGR of 5.2% during the forecast period of 2023-28, cites MarkNtel Advisors in the recent research report. The surge in chronic diseases and health issues has paralleled the need for pharmaceutical products, including sodium chloride-based drugs and intravenous solutions. The growing prevalence of conditions like diabetes, hypertension, and cardiovascular disorders among the population of the Middle East & Africa economies has fueled the demand for pharmaceutical-grade sodium chloride as a crucial ingredient. Changing lifestyles and dietary habits are some of the factors contributing to the escalation of these health conditions. Additionally, the establishment of healthcare infrastructure and pharmaceutical manufacturing facilities in the Middle East and Africa is predicted to further amplify the requirement for pharmaceutical-grade sodium chloride.

Moreover, the expanding role of the private sector in the Middle Eastern health insurance landscape is playing a pivotal role in augmenting the market demand for pharmaceutical-grade sodium chloride in hospitals. As, private insurance providers cover an array of medical conditions, contributing significantly to heightened demand for healthcare services.

Furthermore, governments in the region are strategically focusing on service-based industries like healthcare to enhance revenue streams. This emphasis has led to increased research and development activities, creating a demand for high-quality pharmaceutical-grade sodium chloride to ensure the efficacy and safety of medications. These factors are anticipated to continue to support the demand for pharmaceutical grade sodium chloride, further states the research report, “The Middle East & Africa Pharmaceutical Grade Sodium Chloride Market Analysis, 2023.”

Rising Prevalence of Kidney Patients in the Region Driving Demand for Hemodialysis

Based on the Application segment, the market is further bifurcated into, Channeling Agents, Mechanical Cleansing, Injections, hemodialysis, hemofiltration system, and Peritoneal dialysis. Among them, Hemodialysis is anticipated to hold a substantial market share driven by the region's escalating health concerns surrounding kidney failures. The provided data from the Cleveland Clinic Abu Dhabi underscores the severity of the issue, with over 2000 end-stage renal disease cases reported in the UAE alone as of 2020. The correlation between kidney disease prevalence and the demand for kidney transplants highlights the pivotal role of sodium chloride in various medical procedures related to kidney care.

Further, the projected increase in diabetic and hypertensive patients, due to the growing adoption of sedentary lifestyles specifically among the working and teenage population points to a persistently growing need for kidney dialysis, aligning with the requirement for pharmaceutical-grade sodium chloride. This scenario underscores the interconnectedness of healthcare trends and the demand for specific pharmaceutical components, emphasizing the integral role sodium chloride plays in the region's medical landscape.

The UAE to Hold a Substantial Share with the Increasing R&D, and Expansion of Healthcare Infrastructure and pharmaceutical manufacturers in the Country

Geographically the Middle East & Africa Pharmaceutical Grade Sodium Chloride market is bifurcated into the UAE, Saudi Arabia, Qatar, Israel, and Turkey. Among them, the UAE is anticipated to register a notable growth rate in the forecast years which is intricately linked to the nation's healthcare landscape. The coexistence of government support and private healthcare sectors highlights the multifaceted approach to healthcare enhancement. The confluence of population growth and diverse healthcare needs emphasizes the importance of developing healthcare infrastructure and pharmaceutical production.

The prevalence of hypertension and diabetes signifies the pressing demand for specialized care, which in turn has increased the use of pharmaceutical-grade sodium chloride in treatments. Moreover, the UAE Ministry of Health & Prevention's commitment to reducing hypertension prevalence not only underscores a proactive approach to healthcare but also sustains the demand for sodium chloride in promoting early detection and prevention, reflecting the integral role pharmaceutical components play in the region's healthcare strategies.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market players, including (AzkoNobel (Nouryon), Hebei Huachen, Sudsalz Gmbh, Domuno Salt Ltd., Cargill Incorporated, Tata Chemicals, K+S AG, Cheetham Salt, Swiss Saltworks, US Salts, etc.) are looking forward to strengthening their market position.